<DOC>
	<DOCNO>NCT02696343</DOCNO>
	<brief_summary>Two innovative approach , pulsatile orocutaneous entrainment non-nutritive suck via orosensory entrainment ( NTrainer ) device technology serial salivary gene expression analysis , merge examine relation gene expression , oral somatosensory stimulation , feed behavior , neurodevelopmental outcomes 18 month correct age ( CA ) 180 extremely preterm infant [ EPIs ] ( &lt; 28 week gestational age ( GA ) ) enrol three neonatal intensive care unit : Catholic Health Initiative ( CHI ) Health St. Elizabeth ( Lincoln , NE ) , Tufts Medical Center ( Boston , MA ) , Santa Clara Valley Medical Center ( San Jose , CA ) . EPIs randomize blind pacifier ( SHAM ) PULSED NTrainer treatment group , stratify GA , sex , bronchopulmonary dysplasia status ( BPD vs non-BPD ) . We hypothesize combination NTrainer® intervention improve oral feeding skill , along objective salivary gene expression data monitor response treatment feeding development , result novel , objective , personalized approach neonatal oral feeding reduce duration time attain oral feed improve feeding , growth neurodevelopmental outcomes 18 month ' CA .</brief_summary>
	<brief_title>Somatosensory Modulation Salivary Gene Expression Oral Feeding Preterm Infants</brief_title>
	<detailed_description />
	<mesh_term>Birth Weight</mesh_term>
	<criteria>Extremely preterm infant ( EPIs ) bear 24 0/7 27 6/7 week ' GA , determine obstetric ultrasound &lt; 15 week last menstrual period Enroll EPIs correct PCA ≥ 29 week Approximately equal number male female , exclusion base race/ethnicity Chromosomal congenital anomaly include craniofacial malformation , nervous system anomaly , cyanotic congenital heart disease , gastroschisis , omphalocele , diaphragmatic hernia and/or major gastrointestinal anomaly Congenital infection No document GA Severe IUGR ( 3 % ) Head circumference &lt; 10th &gt; 90th percentile Intracranial hemorrhage grade III IV , seizures Meningitis Neurological examination show abnormal tone movement extremities PCA History necrotizing enterocolitis ( stage II III ) Culturepositive sepsis time study enrollment</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>24 Months</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>somatosensory stimulation</keyword>
	<keyword>orocutaneous</keyword>
	<keyword>gene expression</keyword>
</DOC>